About Weave
At Weave we are on a mission to provide a robust, AI-native platform to address major pain points inherent in the pharma and biotech industries. We are passionate about enhancing customer capabilities with solutions that save significant time, return capacity to teams, lower overall costs, and ultimately decrease the time it takes to get treatments to patients.
How we got here
December 2023
Seed funding from Innovation Endeavors and Magnetic Ventures
March 2024
Early release of AutoIND, our AI-native solution for IND preparation
November 2024
Weave Bio Earns the 2024 “BioTech AI Innovation Of The Year” Award
2024
January 2024
Company launch with a focus on platform development
June 2024
Full commercial launch of AutoIND for pharma and biotech customers
Our Investors
We partner with industry-leading experts to bring the very best technology and insights to the company
Partner with us
Reimagine your regulatory processes.
We are focused on continually enhancing and expanding our capabilities to drive innovation in our industry. By leveraging our best-in-class AI technology, we can impactfully support exceptional science, and get therapies to the market and patients in need.
